Epidemiology of retinal vein occlusions: state-of-the-art
DOI: 10.32364/2311-7729-2021-21-2-86-89
L.К. Moshetova1, S.А. Usharova1, S.V. Simonova1,2, К.I. Turkina1
1Russian Medical Academy of Continuous Professional Education, Moscow,
Russian Federation
2Research Institute of Public Health Organization and Medical Management,
Moscow, Russian Federation
Impaired blood flow in various organs and tissues is a common cause of disabling disorders that even result in a lethal outcome. Despite an extremely rapid development of modern medicine, the rate of these disorders is still high thus emphasizing the importance of further detailed studies on this issue. In addition to systemic vascular diseases, local blood flow disturbances are also prevalent among population. These disturbances result from more significant blood flow disorders. Retinal vein occlusion is not an exclusion. Acute retinal vein occlusions account for more than half of ocular vascular diseases and may lead to extremely severe ophthalmic complications that result in poor vision, blindness, and reduced quality of life in both young and elderly patients. The diversity of clinical presentations, their severity, and clinical course make the diagnosis challenging thus altering the assessment of the prevalence of these diseases.
Keywords: retinal vein occlusion, epidemiology, systemic vascular disorders, risk factors, retinal vessels.
For citation: Moshetova L.К., Usharova S.А., Simonova S.V.,Turkina К.I. Epidemiology of retinal vein occlusions: state-of-the-art. Russian Journal of Clinical Ophthalmology. 2021;21(2):–89. DOI: 10.32364/2311-7729-2021-21-2-86-89.
About the authors:
1Larisa K. Moshetova — Doct. of Sci. (Med.), Professor, Full-Member of the Russian Academy of Sciences, Honored Doctor of Russian Federation, President of the Russian Medical Academy of Continuous Professional Education, Head of the Department of Ophthalmology, ORCID iD 0000-0002-5899-2714;
1Svetlana A. Usharova — postgraduate student of the Depart-ment of Ophthalmology, ORCID iD 0000-0002-0862-514X;
1,2Simona V. Simonova — assistant of the Department of Ophthalmology, Head of the Organizing Methodical Division on Ophthalmology, ORCID iD 0000-0002-1271-1630;
1Kseniya I. Turkina — Cand. Of Sci. (Med.), associate professor of the Department of Ophthalmology, ORCID iD 0000-0002-4989-7467.
1Russian Medical Academy of Continuous Professional Education, 2/1, Barrikadnaya str., Moscow, 125993, Russian Federation.
2Research Institute of Public Health Organization and Medical Management, 9, Sharikopodshipnikovskaya str., Moscow, 115088, Russian Federation.
Contact information: Svetlana A. Usharova, e-mail: svetlalextar@gmail.com. Financial Disclosure: no authors have a financial or property interest in any material or method mentioned. There is no conflict of interests. Received 04.02.2021.
2. Liebreich R. Apoplexia retinae. Graefes Arch Ophthalmol. 1855;1:346–351.
3. Leber T. Diseases of the retina and optic nerves. In Graefe A., Saemisch Т. (eds.): Handbook of the entire ophthalmology. Wilhelm Engelmann Leipsig; 1877.
4. Hayreh S.S. Classification of central retinal vein occlusion. Ophthalmology. 1983;90(5):458–474. DOI: 10.1016/s0161-6420 (83) 34530-9.
5. Varma D.D., Cugati S., Lee A.W. et al. A review of central retinal artery occlusion: clinical presentation and management. Eye (Lond.). 2013;27(6):688–697. DOI: 10.1038/eye.2013.25.
6. Laouri M., Chen E., Looman M. et al. The burden of disease of retinal vein occlusion: review of the literature. Eye (Lond.). 2011;25(8):981–988. DOI: 10.1038/eye.2011.92.
7. Khokhlova D.Yu., Drozdova E.A. Some epidemiology and clinical course characteristics of retinal vein occlusions in present. Vestnik SMUS74. 2014;1(5):89–94 (in Russ.).
8. Feltgen N., Pielen A. Retinal vein occlusion: epidemiology, classification and clinical findings. Ophthalmologe. 2015;112(7):607–618; quiz 619–620 [in German]. DOI: 10.1007/s00347-015-0105-8.
9. Rogers S., McIntosh R.L., Cheung N. et al. International Eye Disease Consortium. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;117(2):313–319.e1. DOI: 10.1016/j.ophtha.2009.07.017.
10. Song P., Xu Y., Zha M. et al. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019;9(1):010427. DOI: 10.7189/jogh.09.010427.
11. Akulenko M.V., Shchuko A.G., Yurieva T.N. Laser surgery of vascular pathology of the eye. Irkutsk: Ophthalmology; 2014 (in Russ.).
12. Kanski J.J. Clinical Ophthalmology. Elsevier Urban and Partner. 2009.
13. Osokin I.G. Optimization of surgical treatment of retinal vein thrombosis outcomes: thesis. M.; 2014 (in Russ.).
14. Pagenstecher H. Contributions to the teaching of hemorrhagic glaucoma. Graefes Arch. Ophthalmol. 1871;17:98–130.
15. Wittström E. Central Retinal Vein Occlusion in Younger Swedish Adults: Case Reports and Review of the Literature. Open Ophthalmol J. 2017;11:89–102. DOI: 10.2174/1874364101711010089.
16. Tsikhonchuk T.V. Retinal vein thrombosis: peculiarities of pathogenesis, prevention of complications: thesis. M.; 2017 (in Russ.).
17. Kiseleva T.N., Ezhov M.V., Adzhemian N.A. et al. Regional ocular blood flow in patients with I–II stage hypertension and subclinical atherosclerosis. Rossiyskiy oftal’mologicheskiy zhurnal. 2016;9(3):26–33. DOI: 10.21516/2072-0076-2016-9-3-26-33 (in Russ.).
18. Ponto K.A., Scharrer I., Binder H. et al. Hypertension and multiple cardiovascular risk factors increase the risk for retinal vein occlusions: results from the Gutenberg Retinal Vein Occlusion Study. J Hypertens. 2019;37(7):1372–1383. DOI: 10.1097/HJH.0000000000002057.
19. Yin X., Li J., Zhang B., Lu P. Association of glaucoma with risk of retinal vein occlusion: A meta-analysis. Acta Ophthalmol. 2019;97(7):652–659. DOI: 10.1111/aos.14141.
20. Kolar P. Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data. J Ophthalmol. 2014;2014:724780. DOI: 10.1155/2014/724780.
21. Altunel O., Atas M., Demircan S. Evaluation of lamina cribrosa thickness in patients diagnosed with central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2019;257(10):2087–2093. DOI: 10.1007/s00417-019-04401-3.
22. Shchuko A.G., Zlobin I.V., Yurieva T.N. Imbalance of intraocular cytokines in retinal vein occlusion and its relationship with the effectiveness of antiangiogenic therapy. Vestnik oftal’mologii. 2015;2:50–58 (in Russ.).
23. Ponto K.A., Elbaz H., Peto T. et al. Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study. J Thromb Haemost. 2015;13(7):1254–1263. DOI: 10.1111/jth.12982.
24. Stem M.S., Talwar N., Comer G.M. et al. A longitudinal analysis of risk factors associated with central retinal vein occlusion. Ophthalmology. 2013;120(2):362–370. DOI: 10.1016/j.ophtha.2012.07.080.
25. Rim T.H., Kim D.W., Han J.S. et al. Retinal vein occlusion and the risk of stroke development: a 9-year nationwide population-based study. Ophthalmology. 2015;122(6):1187–1194. DOI: 10.1016/j.ophtha.2015.01.020.
26. Yasuda M., Kiyohara Y., Arakawa S. et al. Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: the Hisayama study. Invest Ophthalmol Vis Sci. 2010;51(6):3205–3209. DOI: 10.1167/iovs.09-4453.
27. Ehlers J.P., Fekrat S. Retinal vein occlusion: beyond the acute event. Surv Ophthalmol. 2011;56(4):281–299. DOI: 10.1016/j.survophthal.2010.11.006.
28. Khokhlova D. Yu., Drozdova E.A. Analysis of systemic risk factors in patients with retinal vein occlusion. Meditsinskiy vestnik Bashkortostana. 2014;9(2):144–147 (in Russ.).
29. Werther W., Chu L., Holekamp N. et al. Myocardial infarction and cerebrovascular accident in patients with retinal vein occlusion. Arch Ophthalmol. 2011;129(3):326–331. DOI: 10.1001/archophthalmol.2011.2.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Распечатать